Press Esc to close

New vaccine launched to battle typhoid

Hyderabad, Aug 26, 2013, (IANS) : 18:35 IST
Bharat Biotech, a leading biotechnology company specializing in vaccines, Monday launched a new vaccine for typhoid that can be given to infants below two years of age and to adults too.

Typbar-TCV is said to be the world's first clinically proven typhoid conjugate vaccine which can provide long term protection to adults as well as children six months old and above.

Krishna M. Ella, chairman and managing director of Bharat Biotech, told the media that the fourth generation vaccines offers hope to millions around the world as the currently available vaccines lack long-term protection and are not meant for children below two years of age.

The Hyderabad-based company has commenced production of the new vaccine. The plant has the capacity to produce 10 million doses annually, expandable to 50 million doses in future.

Typbar-TCV, which will be available in the market in a couple of weeks, will be supplied to global markets such as South East Asia, South America, Africa, Central Asia and South Asia.

The Rs.300 crore company is already the largest producer and supplier of Vi typhoid vaccine, having distributed over 50 million doses globally.

The existing vaccine in India is available for Rs.180 but the new vaccine is going to cost more. Krishna said the price would be announced soon.

The company invested Rs.65 crore to develop the vaccine, which was evaluated in over 1,200 people at nine clinical sites.

Launching the vaccine, Christian Loucq, Director General of the International Vaccine Institute (IVI), said typhoid every year affects 20 million people and causes 250,000-600,000 deaths, mostly in developing countries.

According to the World Health Organistaion (WHO), 90 percent of typhoid deaths occur in Asia. Most victims are children under five years of age.

Krishna pointed out that 62 percent of the deaths occur in Asia, with India and Pakistan accounting for the highest numbers.

Bharat Biotech gets Rs.40-50 crore of its revenues from the typhoid vaccine launched in 2003. It supplied the vaccine to many countries including Pakistan and Bangladesh where it is part of their national immunization programme.

With the launch of conjugate vaccine, the company hopes to increase the revenue to Rs.100 crore.

Typhoid fever is a life threatening illness caused by the bacterium salmonella typhi, which is transmitted through food or drink contaminated by the faeces or urine of infected people.

"This disease, unfortunately, has been around for too long. In the 21st century, it is not acceptable any more," said Loucq, the head of Seoul-based institute, which has the mission to develop and deliver safe and affordable vaccines for developing nations.

He said the new vaccine would prove effective against typhoid, which has become drug resistant.

S. Sanjay of the Indian Academy of Pediatricians called for re-including typhoid vaccine in the national immunization programme. He pointed out that it was part of the national immunization chart till 1985.

Go to Top

More from this section
Most trending stories
Photo Gallery
A view of Sunder Nursery at Hazrat Nizamuddin in...

A view of Sunder Nursery at Hazrat Nizamuddin in...

Mahila Congress activists make 'pakodas' to protest against alleged unemployement...

Mahila Congress activists make 'pakodas' to protest against alleged unemployement...

Canadian Prime Minister Justin Trudeau and First Lady Sophie Grgoire greet visitors...

Canadian Prime Minister Justin Trudeau and First Lady Sophie Grgoire greet visitors...

Gold medalist Mariama Jamanka of Germany gets lifted by silver medal winner Lauren Gibbs...

Gold medalist Mariama Jamanka of Germany gets lifted by silver medal winner Lauren Gibbs...

Union Textile Minister Smriti Irani addresses a session during UP Investors Summit 2018 at...

Union Textile Minister Smriti Irani addresses a session during UP Investors Summit 2018 at...

A helicopter is seen flying over the besieged town of Douma, Eastern Ghouta...

A helicopter is seen flying over the besieged town of Douma, Eastern Ghouta...

Transgender Shanavi Ponnusamy arrives at the chief minister's cell at...

Transgender Shanavi Ponnusamy arrives at the chief minister's cell at...

Lufthansa tests humanoid robot 'Josie Pepper' at airport...

Lufthansa tests humanoid robot 'Josie Pepper' at airport...

Chief of the Air Staff, Air Chief Marshal B.S. Dhanoa presents a memento to the...

Chief of the Air Staff, Air Chief Marshal B.S. Dhanoa presents a memento to the...

Alpine Skiing - Pyeongchang 2018 Winter Olympics - Women's Downhill Training...

Alpine Skiing - Pyeongchang 2018 Winter Olympics - Women's Downhill Training...

Like us on Facebook

Copyright 2017, The Printers (Mysore) Private Ltd., 75, M.G Road, Post Box 5331, Bengaluru - 560001
Tel: +91 (80) 25880000 Fax No. +91 (80) 25880523
Powered by Yodasoft Technologies Pvt. Ltd.